EFTA01786362

From: Peter Attia Sent: Tuesday, November 29, 2016 5:50 PM To: jeffrey E. Subject: RE: Blood Results from Moskowitz Fri. Nov. 25, 2016 How much? Are you tolerating it ok? Peter Attia, M.D. I Attia Medical, PC The information contained in this transmission may contain privileged and confidential information, including patient information protected by federal and state privacy laws. It is intended only for the use of the person(s) named above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution, or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. From: jeffrey E. [mailto:[email protected] Sent: Tuesday, November 29, 2016 9:49 AM To: Peter Attia Subject: Re: Blood Results from Moskowitz Fri. Nov. 25, 2016 Lipitor On Tue, Nov 29, 2016 at 12:41 PM Peter Attia < > wrote: What meds are you taking? Peter Attia, M.D. I Attia Medical, PC The information contained in this transmission may contain privileged and confidential information, including patient information protected by federal and state privacy laws. It is intended only for the use of the person(s) named EFTA_R1_00109147 EFTA01786362 above. If you are not the intended recipient, you are hereby notified that any review, dissemination, distribution, or duplication of this communication is strictly prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. From: Jeffrey E. [mailto:[email protected] <mailto:[email protected]> Sent: Tuesday, November 29, 2016 9:35 AM To: Peter Attia Subject: Fwd: Blood Results from Moskowitz Fri. Nov. 25, 2016 Forwarded messa e From Date: Tue, Nov 29, 2016 at 12:22 PM Subject: Blood Results from Moskowitz Fri. Nov. 25, 2016 To: Jefffrey Epstein <[email protected] <mailto:[email protected]» please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this 2 EFTA_R1_00109148 EFTA01786363 communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] <[email protected]> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved 3 EFTA_R1_00109149 EFTA01786364